NanOlogy, LLC   Report issue

For profit Phase 2
Founded: Toronto Canada (2015)
Status: No NME R&D (2015)

Organization Overview

First Clinical Trial
2017
NCT03029585
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

NanOlogy, LLC